- Report
- August 2025
- 188 Pages
Global
From €3163EUR$3,545USD£2,789GBP
€3515EUR$3,939USD£3,099GBP
- Report
- August 2025
- 195 Pages
Global
From €3163EUR$3,545USD£2,789GBP
€3515EUR$3,939USD£3,099GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1071EUR$1,200USD£944GBP
€1338EUR$1,500USD£1,180GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1071EUR$1,200USD£944GBP
€1338EUR$1,500USD£1,180GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1428EUR$1,600USD£1,259GBP
€1785EUR$2,000USD£1,574GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €892EUR$1,000USD£787GBP
€1115EUR$1,250USD£983GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €892EUR$1,000USD£787GBP
€1115EUR$1,250USD£983GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1428EUR$1,600USD£1,259GBP
€1785EUR$2,000USD£1,574GBP
- Drug Pipelines
- April 2025
- 50 Pages
Global
From €1071EUR$1,200USD£944GBP
€1338EUR$1,500USD£1,180GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €892EUR$1,000USD£787GBP
€1115EUR$1,250USD£983GBP
- Report
- April 2025
Global
From €4372EUR$4,900USD£3,855GBP
- Report
- February 2025
- 185 Pages
Global
From €4015EUR$4,500USD£3,540GBP
- Report
- August 2025
- 150 Pages
Global
From €3435EUR$3,850USD£3,029GBP
- Report
- July 2025
- 150 Pages
Global
From €3435EUR$3,850USD£3,029GBP
€4328EUR$4,850USD£3,816GBP
- Report
- June 2025
- 150 Pages
Global
From €2408EUR$2,699USD£2,123GBP
- Report
- June 2025
- 200 Pages
Global
From €2489EUR$2,789USD£2,194GBP
- Report
- January 2025
- 95 Pages
Global
From €3500EUR$4,202USD£3,194GBP
- Report
- May 2025
- 134 Pages
Global
From €13380EUR$14,995USD£11,798GBP
- Report
- December 2024
- 59 Pages
Global
From €3565EUR$3,995USD£3,143GBP
- Report
- June 2025
Global
From €6692EUR$7,500USD£5,901GBP

The HIV/AIDS Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs to treat HIV/AIDS. These drugs are used to treat the virus itself, as well as the symptoms and complications associated with it. HIV/AIDS drugs are typically divided into two categories: antiretroviral drugs, which are used to suppress the virus, and prophylactic drugs, which are used to prevent the transmission of the virus.
The HIV/AIDS Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Gilead Sciences, Merck, GlaxoSmithKline, Bristol-Myers Squibb, and Pfizer. These companies are constantly developing new drugs and treatments to improve the quality of life for those living with HIV/AIDS. Show Less Read more